Detalhe da pesquisa
1.
Efficacy and Safety of Switching to the 2-Drug Regimen Dolutegravir/Lamivudine Versus Continuing a 3- or 4-Drug Regimen for Maintaining Virologic Suppression in Adults Living With Human Immunodeficiency Virus 1 (HIV-1): Week 48 Results From the Phase 3, Noninferiority SALSA Randomized Trial.
Clin Infect Dis
; 76(4): 720-729, 2023 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35235656
2.
A proposed modification to Hy's law and Edish criteria in oncology clinical trials using aggregated historical data.
Pharmacoepidemiol Drug Saf
; 22(6): 571-8, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23300062
3.
Truncated robust distance for clinical laboratory safety data monitoring and assessment.
J Biopharm Stat
; 22(6): 1174-92, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23075016
4.
Three-year durable efficacy of dolutegravir plus lamivudine in antiretroviral therapy - naive adults with HIV-1 infection.
AIDS
; 36(1): 39-48, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34534138
5.
Incident type 2 diabetes mellitus after initiation of common HIV antiretroviral drugs.
AIDS
; 35(1): 81-90, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33048874
6.
Hypersensitivity reactions, hepatotoxicity, and other discontinuations in persons receiving integrase strand transfer inhibitors: results from the EuroSIDA study.
HIV Res Clin Pract
; 22(6): 160-168, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34779362
7.
Brief Report: Weight Gain Following ART Initiation in ART-Naïve People Living With HIV in the Current Treatment Era.
J Acquir Immune Defic Syndr
; 86(3): 339-343, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33148997
8.
Antiretroviral therapy and liver disorders in the OPERA® cohort.
Ther Adv Drug Saf
; 11: 2042098620976953, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33343858
9.
Psychiatric outcomes observed in patients living with HIV using six common core antiretrovirals in the Observational Pharmaco-Epidemiology Research and Analysis database.
Ther Adv Drug Saf
; 9(12): 675-686, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30546862
10.
Psychiatric Symptoms in Patients Receiving Dolutegravir.
J Acquir Immune Defic Syndr
; 74(4): 423-431, 2017 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27984559
11.
Postmarketing Surveillance of Pregnancy Outcomes With Dolutegravir Use.
J Acquir Immune Defic Syndr
; 83(1): e2-e5, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31809366
12.
Risk of myocardial infarction and abacavir therapy: no increased risk across 52 GlaxoSmithKline-sponsored clinical trials in adult subjects.
J Acquir Immune Defic Syndr
; 51(1): 20-8, 2009 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19282778